• 1. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 2. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 3. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 4. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 5. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Diphenylethers

Research Brief on Methyl 3-(p-tolyloxy)benzoate (CAS: 78303-09-0): Recent Advances and Applications in Chemical Biology and Medicine

Methyl 3-(p-tolyloxy)benzoate (CAS: 78303-09-0) is a synthetic organic compound that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its versatile applications and potential therapeutic properties. Recent studies have explored its role as a key intermediate in the synthesis of bioactive molecules, as well as its direct pharmacological effects. This research brief aims to summarize the latest findings related to this compound, highlighting its chemical properties, synthetic pathways, and emerging biological activities.

One of the most notable advancements in the study of Methyl 3-(p-tolyloxy)benzoate is its application in the development of novel anti-inflammatory agents. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibit potent inhibitory effects on cyclooxygenase-2 (COX-2), a key enzyme involved in inflammatory processes. The researchers synthesized a series of analogs and evaluated their COX-2 selectivity, identifying several candidates with improved efficacy and reduced side effects compared to traditional nonsteroidal anti-inflammatory drugs (NSAIDs).

In addition to its anti-inflammatory potential, Methyl 3-(p-tolyloxy)benzoate has been investigated for its role in cancer therapy. A recent preprint article (2024) from a collaborative research team at Harvard Medical School and MIT reported that this compound can modulate the activity of certain oncogenic signaling pathways, particularly those involving the PI3K/AKT/mTOR cascade. The study utilized in vitro and in vivo models to demonstrate that Methyl 3-(p-tolyloxy)benzoate derivatives induce apoptosis in cancer cells while sparing normal cells, suggesting a promising avenue for targeted cancer treatments.

The synthetic accessibility of Methyl 3-(p-tolyloxy)benzoate has also been a focus of recent research. A 2023 paper in Organic Letters described a novel, eco-friendly catalytic method for its synthesis, employing palladium nanoparticles supported on graphene oxide. This method achieved a high yield (92%) and excellent selectivity, addressing previous challenges related to harsh reaction conditions and low efficiency. Such advancements in synthesis are critical for scaling up production and facilitating further pharmacological studies.

Beyond its therapeutic applications, Methyl 3-(p-tolyloxy)benzoate has been explored as a tool compound in chemical biology. Researchers have utilized its structural features to design fluorescent probes for imaging cellular processes. A 2024 study in ACS Chemical Biology highlighted the development of a Methyl 3-(p-tolyloxy)benzoate-based probe that selectively binds to lipid droplets, enabling real-time visualization of lipid metabolism in live cells. This innovation opens new possibilities for studying metabolic disorders such as obesity and diabetes.

Despite these promising developments, challenges remain in the clinical translation of Methyl 3-(p-tolyloxy)benzoate-based therapies. Issues such as pharmacokinetic optimization, toxicity profiling, and formulation stability need to be addressed in future studies. However, the compound's versatility and the growing body of research supporting its biological activities make it a compelling candidate for further investigation. Ongoing efforts are expected to uncover additional applications, particularly in the realms of neurodegenerative diseases and antimicrobial resistance.

In conclusion, Methyl 3-(p-tolyloxy)benzoate (CAS: 78303-09-0) represents a multifaceted compound with significant potential in chemical biology and medicine. Recent studies have expanded our understanding of its synthetic routes, biological activities, and therapeutic applications, paving the way for innovative drug development and diagnostic tools. As research progresses, this compound is likely to play an increasingly important role in addressing unmet medical needs.

• 367519-84-4(Methyl 3-(hydroxymethyl)-5-methoxybenzoate)
• 38342-84-6(Methyl 4-(4-methoxyphenoxy)benzoate)
• 14387-30-5(Dimethyl-4',4-oxybis(benzoate))
• 50789-43-0(Methyl 3-Phenoxybenzoate)
• 100915-02-4(Benzoic acid, 4-(4-formylphenoxy)-, methyl ester)
• 71590-08-4(3-Methoxy-5-(methoxycarbonyl)benzoic acid)
• 5368-81-0(Methyl 3-methoxybenzoate)
• 103561-09-7(Benzoic acid,3-(4-formylphenoxy)-, methyl ester)
• 108593-44-8(Methyl 3-methoxy-5-methylbenzoate)
• 20319-44-2(Dimethyl 5-methoxyisophthalate)